Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 66

1.

Benzodiazepine Use and Long-Term Mortality in Real-Life Chronic Heart Failure Outpatients: A Cohort Analysis.

Diez-Quevedo C, Lupon J, de Antonio M, Domingo M, Martin-Subero M, Rangil T, Moliner P, Zamora E, Altimir S, Santesmases J, Troya MI, Boldo M, de Pablo J, Bayes-Genis A.

Psychother Psychosom. 2018 Oct 10:1-3. doi: 10.1159/000491879. [Epub ahead of print] No abstract available.

PMID:
30304738
2.

Circulating monocyte subsets and heart failure prognosis.

Elchinova E, Teubel I, Roura S, Fernández MA, Lupón J, Gálvez-Montón C, de Antonio M, Moliner P, Domingo M, Zamora E, Núñez J, Cediel G, Bayés-Genís A.

PLoS One. 2018 Sep 21;13(9):e0204074. doi: 10.1371/journal.pone.0204074. eCollection 2018.

3.

Comorbidities, Fragility, and Quality of Life in Heart Failure Patients With Midrange Ejection Fraction.

Gastelurrutia P, Lupón J, Moliner P, Yang X, Cediel G, de Antonio M, Domingo M, Altimir S, González B, Rodríguez M, Rivas C, Díaz V, Fung E, Zamora E, Santesmases J, Núñez J, Woo J, Bayes-Genis A.

Mayo Clin Proc Innov Qual Outcomes. 2018 Apr 19;2(2):176-185. doi: 10.1016/j.mayocpiqo.2018.02.004. eCollection 2018 Jun.

4.

Late-onset Pompe disease in France: molecular features and epidemiology from a nationwide study.

Semplicini C, Letard P, De Antonio M, Taouagh N, Perniconi B, Bouhour F, Echaniz-Laguna A, Orlikowski D, Sacconi S, Salort-Campana E, Solé G, Zagnoli F, Hamroun D, Froissart R, Caillaud C, Laforêt P; French Pompe Study Group.

J Inherit Metab Dis. 2018 Aug 28. doi: 10.1007/s10545-018-0243-7. [Epub ahead of print]

PMID:
30155607
5.

Dynamic Trajectories of Left Ventricular Ejection Fraction in Heart Failure.

Lupón J, Gavidia-Bovadilla G, Ferrer E, de Antonio M, Perera-Lluna A, López-Ayerbe J, Domingo M, Núñez J, Zamora E, Moliner P, Díaz-Ruata P, Santesmases J, Bayés-Genís A.

J Am Coll Cardiol. 2018 Aug 7;72(6):591-601. doi: 10.1016/j.jacc.2018.05.042.

PMID:
30071987
6.

Advanced interatrial block predicts new-onset atrial fibrillation and ischemic stroke in patients with heart failure: The "Bayes' Syndrome-HF" study.

Escobar-Robledo LA, Bayés-de-Luna A, Lupón J, Baranchuk A, Moliner P, Martínez-Sellés M, Zamora E, de Antonio M, Domingo M, Cediel G, Núñez J, Santiago-Vacas E, Bayés-Genís A.

Int J Cardiol. 2018 Nov 15;271:174-180. doi: 10.1016/j.ijcard.2018.05.050. Epub 2018 May 18.

PMID:
29801761
7.

Predictive biomarkers for death and rehospitalization in comorbid frail elderly heart failure patients.

Pacho C, Domingo M, Núñez R, Lupón J, Núñez J, Barallat J, Moliner P, de Antonio M, Santesmases J, Cediel G, Roura S, Pastor MC, Tor J, Bayes-Genis A.

BMC Geriatr. 2018 May 9;18(1):109. doi: 10.1186/s12877-018-0807-2.

8.

Muscle ischaemia associated with NXP2 autoantibodies: a severe subtype of juvenile dermatomyositis.

Aouizerate J, De Antonio M, Bader-Meunier B, Barnerias C, Bodemer C, Isapof A, Quartier P, Melki I, Charuel JL, Bassez G, Desguerre I, Gherardi RK, Authier FJ, Gitiaux C.

Rheumatology (Oxford). 2018 May 1;57(5):873-879. doi: 10.1093/rheumatology/kex516.

PMID:
29474663
9.

Telomere attrition in heart failure: a flow-FISH longitudinal analysis of circulating monocytes.

Teubel I, Elchinova E, Roura S, Fernández MA, Gálvez-Montón C, Moliner P, de Antonio M, Lupón J, Bayés-Genís A.

J Transl Med. 2018 Feb 20;16(1):35. doi: 10.1186/s12967-018-1412-z.

10.

Bio-profiling and bio-prognostication of chronic heart failure with mid-range ejection fraction.

Moliner P, Lupón J, Barallat J, de Antonio M, Domingo M, Núñez J, Zamora E, Galán A, Santesmases J, Pastor C, Bayes-Genis A.

Int J Cardiol. 2018 Apr 15;257:188-192. doi: 10.1016/j.ijcard.2018.01.119. Epub 2018 Jan 31.

PMID:
29415801
11.

Impact of a 'stent for life' initiative on post-ST elevation myocardial infarction heart failure: a 15 year heart failure clinic experience.

Bayes-Genis A, García C, de Antonio M, Fernandez-Nofrerías E, Domingo M, Zamora E, Moliner P, Lupón J.

ESC Heart Fail. 2018 Feb;5(1):101-105. doi: 10.1002/ehf2.12245. Epub 2017 Dec 29.

12.

Clinical characteristics, one-year change in ejection fraction and long-term outcomes in patients with heart failure with mid-range ejection fraction: a multicentre prospective observational study in Catalonia (Spain).

Farré N, Lupon J, Roig E, Gonzalez-Costello J, Vila J, Perez S, de Antonio M, Solé-González E, Sánchez-Enrique C, Moliner P, Ruiz S, Enjuanes C, Mirabet S, Bayés-Genís A, Comin-Colet J; GICCAT Investigators.

BMJ Open. 2017 Dec 21;7(12):e018719. doi: 10.1136/bmjopen-2017-018719.

13.

Barcelona Bio-HF Calculator Version 2.0: incorporation of angiotensin II receptor blocker neprilysin inhibitor (ARNI) and risk for heart failure hospitalization.

Lupón J, Simpson J, McMurray JJV, de Antonio M, Vila J, Subirana I, Barallat J, Moliner P, Domingo M, Zamora E, Bayes-Genis A.

Eur J Heart Fail. 2018 May;20(5):938-940. doi: 10.1002/ejhf.949. Epub 2017 Sep 26. No abstract available.

PMID:
28949101
14.

Prognostic value of circulating microRNAs on heart failure-related morbidity and mortality in two large diverse cohorts of general heart failure patients.

Bayés-Genis A, Lanfear DE, de Ronde MWJ, Lupón J, Leenders JJ, Liu Z, Zuithoff NPA, Eijkemans MJC, Zamora E, De Antonio M, Zwinderman AH, Pinto-Sietsma SJ, Pinto YM.

Eur J Heart Fail. 2018 Jan;20(1):67-75. doi: 10.1002/ejhf.984. Epub 2017 Sep 26.

PMID:
28949058
15.

Long term longitudinal study of muscle function in patients with glycogen storage disease type IIIa.

Decostre V, Laforêt P, De Antonio M, Kachetel K, Canal A, Ollivier G, Nadaj-Pakleza A, Petit FM, Wahbi K, Fayssoil A, Eymard B, Behin A, Labrune P, Hogrel JY.

Mol Genet Metab. 2017 Nov;122(3):108-116. doi: 10.1016/j.ymgme.2017.08.010. Epub 2017 Aug 30.

PMID:
28888851
16.

Effect of enzyme replacement therapy with alglucosidase alfa (Myozyme®) in 12 patients with advanced late-onset Pompe disease.

Papadopoulos C, Orlikowski D, Prigent H, Lacour A, Tard C, Furby A, Praline J, Solé G, Hogrel JY, De Antonio M, Semplicini C, Deibener-Kaminsky J, Kaminsky P, Eymard B, Taouagh N, Perniconi B, Hamroun D, Laforêt P; French Pompe Study Group.

Mol Genet Metab. 2017 Sep;122(1-2):80-85. doi: 10.1016/j.ymgme.2017.06.007. Epub 2017 Jun 20.

PMID:
28648663
17.

Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.

Lupón J, Díez-López C, de Antonio M, Domingo M, Zamora E, Moliner P, González B, Santesmases J, Troya MI, Bayés-Genís A.

Eur J Heart Fail. 2017 Dec;19(12):1615-1623. doi: 10.1002/ejhf.824. Epub 2017 Apr 6.

PMID:
28387002
18.

Bloodstream Amyloid-beta (1-40) Peptide, Cognition, and Outcomes in Heart Failure.

Bayes-Genis A, Barallat J, de Antonio M, Domingo M, Zamora E, Vila J, Subirana I, Gastelurrutia P, Pastor MC, Januzzi JL, Lupón J.

Rev Esp Cardiol (Engl Ed). 2017 Nov;70(11):924-932. doi: 10.1016/j.rec.2017.02.021. Epub 2017 Mar 6. English, Spanish.

PMID:
28279654
19.

Early Postdischarge STOP-HF-Clinic Reduces 30-day Readmissions in Old and Frail Patients With Heart Failure.

Pacho C, Domingo M, Núñez R, Lupón J, Moliner P, de Antonio M, González B, Santesmases J, Vela E, Tor J, Bayes-Genis A.

Rev Esp Cardiol (Engl Ed). 2017 Aug;70(8):631-638. doi: 10.1016/j.rec.2017.01.003. Epub 2017 Feb 16. English, Spanish.

PMID:
28215922
20.

Long-term exposure to Myozyme results in a decrease of anti-drug antibodies in late-onset Pompe disease patients.

Masat E, Laforêt P, De Antonio M, Corre G, Perniconi B, Taouagh N, Mariampillai K, Amelin D, Mauhin W, Hogrel JY, Caillaud C, Ronzitti G, Puzzo F, Kuranda K, Colella P, Mallone R, Benveniste O, Mingozzi F; French Pompe Registry Study Group.

Sci Rep. 2016 Nov 4;6:36182. doi: 10.1038/srep36182.

Supplemental Content

Loading ...
Support Center